NO20054157D0 - Formuleringer av venlafaksin med forsinket frigjoring - Google Patents

Formuleringer av venlafaksin med forsinket frigjoring

Info

Publication number
NO20054157D0
NO20054157D0 NO20054157A NO20054157A NO20054157D0 NO 20054157 D0 NO20054157 D0 NO 20054157D0 NO 20054157 A NO20054157 A NO 20054157A NO 20054157 A NO20054157 A NO 20054157A NO 20054157 D0 NO20054157 D0 NO 20054157D0
Authority
NO
Norway
Prior art keywords
delayed
release venlafaxine
formulations
venlafaxine formulations
release
Prior art date
Application number
NO20054157A
Other languages
English (en)
Other versions
NO20054157L (no
Inventor
Fjalar Johannsson
Birkir Arnason
Original Assignee
Actavis Group Hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IS6710A external-priority patent/IS6710A/is
Priority claimed from IS7143A external-priority patent/IS7143A/is
Application filed by Actavis Group Hf filed Critical Actavis Group Hf
Publication of NO20054157D0 publication Critical patent/NO20054157D0/no
Publication of NO20054157L publication Critical patent/NO20054157L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
NO20054157A 2003-02-07 2005-09-07 Formuleringer av venlafaksin med forsinket frigjoring NO20054157L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS6710A IS6710A (is) 2003-02-07 2003-02-07 Venlafaxín samsetningar með seinkaða losun
IS7143A IS7143A (is) 2004-02-05 2004-02-05 Venlafaxín samsetningar með seinkaða losun
PCT/IS2004/000003 WO2004069228A2 (en) 2003-02-07 2004-02-09 Sustained release formulations of venlafaxine

Publications (2)

Publication Number Publication Date
NO20054157D0 true NO20054157D0 (no) 2005-09-07
NO20054157L NO20054157L (no) 2005-11-03

Family

ID=32852478

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054157A NO20054157L (no) 2003-02-07 2005-09-07 Formuleringer av venlafaksin med forsinket frigjoring

Country Status (6)

Country Link
US (1) US20060246132A1 (no)
EP (1) EP1596837A2 (no)
EA (1) EA011579B1 (no)
IS (1) IS8011A (no)
NO (1) NO20054157L (no)
WO (1) WO2004069228A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL377473A1 (pl) * 2002-11-28 2006-02-06 Themis Laboratories Private Limited Sposób produkcji mikropeletek o przedłużonym uwalnianiu zawierających chlorowodorek wenlafaksyny
CZ20033294A3 (cs) * 2003-12-03 2005-06-15 Zentiva, A.S. Potahovaná tableta s obsahem venlafaxinu nebo jeho solí s řízeným uvolňováním
WO2005074895A1 (en) * 2004-02-04 2005-08-18 Alembic Limited Extended release coated microtablets of venlafaxine hydrochloride
US20090175934A1 (en) * 2006-03-08 2009-07-09 Jubilant Organosys Ltd. Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
CZ307916B6 (cs) * 2017-05-08 2019-08-21 mcePharma s. r. o. Orodispergovatelná tableta s biodostupným kurkuminem a její použití

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
DE60038698T2 (de) * 1999-12-23 2009-05-07 Pfizer Products Inc., Groton Hydrogel-gesteuerte dosierungsform
EP1474123A1 (en) * 2002-01-03 2004-11-10 LEK Pharmaceuticals D.D. Controlled release pharmaceutical formulation containing venlafaxine
AU2003226748A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Compositions of venlafaxine base
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride

Also Published As

Publication number Publication date
EP1596837A2 (en) 2005-11-23
WO2004069228A2 (en) 2004-08-19
EA200501262A1 (ru) 2006-04-28
WO2004069228A3 (en) 2004-09-16
US20060246132A1 (en) 2006-11-02
NO20054157L (no) 2005-11-03
EA011579B1 (ru) 2009-04-28
IS8011A (is) 2005-09-06

Similar Documents

Publication Publication Date Title
IS8309A (is) Lyfjablöndur
NO2015003I1 (no) bupropionhydroklorid
IS8323A (is) Ný amínóbensófenónefnasambönd
IL162642A0 (en) Formulations
IL174432A (en) Pantoprazole multiparticulate formulations
DE602004002966D1 (de) Spritzdüse
PT1501534E (pt) Formulacoes farmaceuticas
DE602004017700D1 (de) Transmukosen verabreichung
DE502004010381D1 (de) Um
DK1670440T3 (da) HRT formuleringer
IS2787B (is) Módafíníllyfjasamsetningar með breytta losun
DE602004018602D1 (de) Mikrospiegel
GB0323701D0 (en) Formulations
EP1673073A4 (en) SLOW RELEASE FORMULATIONS
DK1597171T3 (da) Terapeutisk mikroskum
NO20060375L (no) Famasoytisk preparat
NO20054157D0 (no) Formuleringer av venlafaksin med forsinket frigjoring
IL174308A0 (en) Therapeutic formulations
GB0307765D0 (en) Tissue-adhesive formulations
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
FR2834647B1 (fr) Putter
IS6710A (is) Venlafaxín samsetningar með seinkaða losun
DE602004028915D1 (de) Therapeutische zusammensetzungen
NO20031670D0 (no) Nytt radiofarmasöytisk preparat
DOS2003000726S (es) Confiteria

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application